Inventor
WALL MARK
US25 patents
⚠️ This page may combine multiple inventors who share the name “WALL MARK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICA NV
18 patentsUS7414050B2Aug 19, 2008
Inhibitors of c-fms kinase
JANSSEN PHARMACEUTICA NV36 citations95
US10428134B2Oct 1, 2019
Immunoglobulins and uses thereof
JANSSEN PHARMACEUTICA NV7 citations92
US7973035B2Jul 5, 2011
Inhibitors of C-FMS kinase
JANSSEN PHARMACEUTICA NV24 citations92
US9453002B2Sep 27, 2016
Substituted imidazoles as N-type calcium channel blockers
JANSSEN PHARMACEUTICA NV18 citations90
US10968264B2Apr 6, 2021
Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
JANSSEN PHARMACEUTICA NV2 citations84
US8895584B2Nov 25, 2014
Inhibitors of c-fms kinase
JANSSEN PHARMACEUTICA NV4 citations84
US10640544B2May 5, 2020
Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
JANSSEN PHARMACEUTICA NV4 citations83
US9434693B2Sep 6, 2016
Substituted pyrazoles as N-type calcium channel blockers
JANSSEN PHARMACEUTICA NV19 citations83
US8901314B2Dec 2, 2014
Substituted pyrazoles as N-type calcium channel blockers
JANSSEN PHARMACEUTICA NV12 citations83
US11230526B1Jan 25, 2022
Cylcoalkenyl derivatives useful as agonists of the GPR120 and/or GPR40 receptors
JANSSEN PHARMACEUTICA NV2 citations72
US9296726B2Mar 29, 2016
Inhibitors of c-fms kinase
JANSSEN PHARMACEUTICA NV2 citations62
US9221797B2Dec 29, 2015
Inhibitors of c-fms kinase
JANSSEN PHARMACEUTICA NV2 citations62
US8759347B2Jun 24, 2014
Inhibitors of C-FMS kinase
JANSSEN PHARMACEUTICA NV3 citations61
US9452996B2Sep 27, 2016
Inhibitors of c-fms kinase
JANSSEN PHARMACEUTICA NV0 citations52
US9403804B2Aug 2, 2016
Inhibitors of c-fms kinase
JANSSEN PHARMACEUTICA NV0 citations52
US9394289B2Jul 19, 2016
Inhibitors of c-fms kinase
JANSSEN PHARMACEUTICA NV0 citations52
US10653673B2May 19, 2020
Substituted imidazoles as N-type calcium channel blockers
JANSSEN PHARMACEUTICA NV0 citations50
US9974775B2May 22, 2018
Substituted imidazoles as N-type calcium channel blockers
JANSSEN PHARMACEUTICA NV1 citations50
ILLIG CARL R
4 patentsDIMENSIONAL PHARM INC
2 patentsUS7109354B2Sep 19, 2006
Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
DIMENSIONAL PHARM INC17 citations91
US7138530B2Nov 21, 2006
Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
DIMENSIONAL PHARM INC29 citations90